// App-Quantinova.ai

81 : RNA-seq, exome-seq, functional RNAi screening and bioinformatics analyses identify molecules promoting aberrant activation of classical and alternative NF-kB pathways in head and neck cell lines

Researchers

Presenter

  • Hui Cheng

Principal Investigators

  • Xinping Yang

  • Anthony Saleh

  • Shaleeka Cornelius

  • Carter Van Waes

  • Zhong Chen

  • Emine Guven-Maiorov

  • Ozlem Keskin

  • Attila Gursoy

  • Ruth Nussinov

Medical Centers

  • NIH/NIMHD, Bethesda, MD

  • Cancer and Inflammation Program, Leidos Biomedical Research, Inc. Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, MD

  • Department of Chemical and Biological Engineering Center for Computational Biology and Bioinformatics, Koc University, Istanbul, Turkey

  • Center for Computational Biology and Bioinformatics Department of Computer Engineering, Koc University, Istanbul, Turkey.

Locations

  • United States

  • Turkey

Companies

  • Leidos Biomedical Re

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Squamous cell carcinoma of the head and neck

  • Solid malignancies

Biomarkers

  • Tumor necrosis factor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A